190
Views
12
CrossRef citations to date
0
Altmetric
PTEN Radiosensitises Hepatocellular Carcinoma Cells

Radiation-inducible PTEN expression radiosensitises hepatocellular carcinoma cells

, , , , &
Pages 964-974 | Received 09 Feb 2010, Accepted 11 May 2010, Published online: 02 Aug 2010

References

  • Bertram J, Peacock JW, Tan C, Mui AL, Chung SW, Gleave ME, Dedhar S, Cox ME, Ong CJ. 2006. Inhibition of the phosphatidylinositol 3′-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells. Cancer Research 66:4781–4788.
  • Chu EC, Tarnawski AS. 2004. PTEN regulatory functions in tumor suppression and cell biology. Medical Science Monitor 10:RA235–RA241.
  • Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan D, Weichselbaum RR, Kufe DW. 1992. Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proceedings of the National Academy of Sciences of the USA 89:10149–10153.
  • Gottschalk AR, Doan A, Nakamura JL, Stokoe D, Haas-Kogan DA. 2005. Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB-dependent mechanism. International Journal of Radiation Oncology, Biology Physics 63:1221–1227.
  • Hingorani M, White CL, Agrawal VK, Vidal L, Melcher A, Harrington KJ. 2007. Combining radiation and cancer gene therapy: A potential marriage of physical and biological targeting? Current Cancer Drug Targets 7:389–409.
  • Hinz JM, Yamada NA, Salazar EP, Tebbs RS, Thompson LH. 2005. Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells. DNA Repair 4:782–792.
  • Jiang Z, Pore N, Cerniglia GJ, Mick R, Georgescu MM, Bernhard EJ, Hahn SM, Gupta AK, Maity A. 2007. Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Research 67:4467–4473.
  • Kotelevets L, Van Hengel J, Bruyneel E, Mareel M, Van Roy F, Chastre E. 2001. The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. The Journal of Cell Biology 155:1129–1135.
  • Lee C, Kim JS, Waldman T. 2004. PTEN gene targeting reveals a radiation-induced size checkpoint in human cancer cells. Cancer Research 64:6906–6914.
  • Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N, Parsons R. 1998. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Research 58:5667–5672.
  • Liang K, Jin W, Knuefermann C, Schmidt M, Mills GB, Ang KK, Milas L, Fan Z. 2003. Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy. Molecular Cancer Therapeutics 2:353–360.
  • Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, Mcmurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. 2003. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. The Journal of Biological Chemistry 278:40057–40066.
  • McKenna WG, Muschel RJ. 2003. Targeting tumor cells by enhancing radiation sensitivity. Genes, Chromosomes & Cancer 38:330–338.
  • McKenna WG, Muschel RJ, Gupta A, Hahn S, Bernhard EJ. 2003a. Signaling inhibition with radiation in colorectal cancer: Clinical trials. Seminars in Oncology 30:56–67.
  • McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ. 2003b. The RAS signal transduction pathway and its role in radiation sensitivity. Oncogene 22:5866–5875.
  • Moretti L, Attia A, Kim KW, Lu B. 2007. Crosstalk between Bak/Bax and mTOR signaling regulates radiation-induced autophagy. Autophagy 3:142–144.
  • Myers MP, Pass I, Batty IH, Van Der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. 1998. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proceedings of the National Academy of Sciences of the USA 95:13513–13518.
  • Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA. 2005. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas. Journal of Neuro-Oncology 71:215–222.
  • Pappas G, Zumstein LA, Munshi A, Hobbs M, Meyn RE. 2007. Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity. Cancer Gene Therapy 14:543–549.
  • Park JK, Jung HY, Park SH, Kang SY, Yi MR, Um HD, Hong SH. 2008. Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells. International Journal of Radiation Oncology, Biology, Physics 70:1552–1560.
  • Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R. 1999. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proceedings of the National Academy of Sciences of the USA 96:1563–1568.
  • Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonnell TJ, Kuban DA, Meyn RE. 2004. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Therapy 11:273–279.
  • Saito Y, Gopalan B, Mhashilkar AM, Roth JA, Chada S, Zumstein L, Ramesh R. 2003. Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells. Cancer Gene Therapy 10:803–813.
  • Seong J, Park HC, Han KH, Chon CY. 2003. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. International Journal of Radiation Oncology, Biology, Physics 55:329–336.
  • Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 15:356–362.
  • Tomioka A, Tanaka M, De Velasco MA, Anai S, Takada S, Kushibiki T, Tabata Y, Rosser CJ, Uemura H, Hirao Y. 2008. Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Molecular Cancer Therapeutics 7:1864–1870.
  • Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA. 2008. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Journal of Clinical Oncology 26:657–664.
  • Tsurushima H, Yuan X, Dillehay LE, Leong KW. 2008. Radiation-inducible caspase-8 gene therapy for malignant brain tumors. International Journal of Radiation Oncology, Biology, Physics 71:517–525.
  • Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, De Belle I. 2001. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nature Cell Biology 3:1124–1128.
  • Wang L, Wang WL, Zhang Y, Guo SP, Zhang J, Li QL. 2007. Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatology Research 37:389–396.
  • Weng L, Brown J, Eng C. 2001. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and independent pathways. Human Molecular Genetics 10:237–242.
  • Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M. 1999. PTEN gene transfer in human malignant glioma: Sensitization to irradiation and CD95L-induced apoptosis. Oncogene 18:3936–3943.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.